Michael Shatsky
About Michael Shatsky
Michael Shatsky is the Head of CAR T Onboarding at Bristol Myers Squibb in Montreal, Quebec, Canada, with extensive experience in oncology and CAR T cell therapy.
Title
Michael Shatsky currently works as the Head of CAR T Onboarding at Bristol Myers Squibb in Montreal, Quebec, Canada.
Current Role at Bristol Myers Squibb
Michael Shatsky leads the CAR T Onboarding at Bristol Myers Squibb. In this role, he is responsible for overseeing the onboarding processes related to CAR T cell therapies, ensuring seamless integration and execution. This position emphasizes his expertise in CAR T cell therapy, which is a specialized and rapidly evolving field in oncology treatments.
Previous Roles at Bristol Myers Squibb
Michael Shatsky has held various roles at Bristol Myers Squibb, including Senior Ide-cel Marketing Lead (CAR T Cell Therapy) in 2020, Oncology Franchise & Biomarker Lead from 2018 to 2020, Oncology Franchise Lead & Strategic Advisor to the President from 2016 to 2018, and Oncology Launch Excellence Manager in 2016. His tenure at the company has involved strategic advising, marketing leadership, and the launch of multiple oncology products.
Career at Lundbeck
Before joining Bristol Myers Squibb, Michael Shatsky worked at Lundbeck as a Product Manager from 2013 to 2016 and as an Associate Product Manager from 2012 to 2013. At Lundbeck, he was responsible for developing marketing strategies and managing product launches, contributing significantly to the company's product portfolio in the pharmaceutical market.
Educational Background
Michael Shatsky studied at Concordia University, where he earned an MBA from 2008 to 2010. Additionally, he completed a BSc with a Specialization in Environmental Science from 2003 to 2007. His education has provided him with a strong foundation in business management and environmental science, which has been instrumental in his professional career.